Clinical Trials in Baltimore

Showing 17481-17500 of 23,476 trials

ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals

NCT02379104

ROTEM® sigma is a new thromboelastometric coagulation analysis system. The new system is fully automated allowing for a simple and safe operation compared to its predecessor model ROTEM® delta. Method comparison of ROTEM® sigma with predecessor model ROTEM® delta) - confirmation of equality. Confirmation of reference intervals of the ROTEM® systems.

Blood Coagulation Disorders

Tem Innovations GmbH240 participantsStarted Oct 2017

Orlando, Florida, United States • Baltimore, Maryland, United States • New York, New York, United States +2 more locations

COMPLETEDPhase 2/3< 1 mile

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

NCT00357370

The purpose of this clinical research study is to learn if BMS-512148, added to insulin and one or two anti-diabetes medications (metformin and/or pioglitazone or rosiglitazone), can help reduce the blood sugar levels compared to insulin and one or two anti-diabetes medications (metformin and/or pioglitazone or rosiglitazone) alone, in subjects with type 2 diabetes. The safety of this treatment will also be studied.

Type 2 Diabetes

AstraZeneca163 participantsStarted Oct 2006

Jonesboro, Arkansas, United States • Fresno, California, United States • Greenbrae, California, United States +20 more locations

ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

Find Trials by Condition in Baltimore

Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence

Computerized Alcohol Misuse Intervention System for Health Care

Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects

Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols

Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis

REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction

Utilizing Blood Volume Measurements in the Treatment of Heart Failure Patients

Pharmacogenetic Response to Naltrexone For Alcohol Dependence

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Dose-Escalation Study of GSK2126458

Ovarian Cancer Vaccine for Patients in Remission

Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy

Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome

Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access

Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism

Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)